Science

Science, technology and the emergence of AI have converged to make precision medicine for acute care a reality. This is how we deliver healthcare tailored to biology.

Research & Development

Evidence

Clinical Trials

The Sepsis ImmunoScore® Predicts Sepsis, Mortality, and Deterioration Better than Clinical Scores and Widely Available Biomarkers

Read More →

Products

Prenosis is developing a pipeline of integrated diagnostics and therapeutics grounded in each patient's unique biological profile, using deep data science and AI to give clinicians tools that reflect the true complexity of critical disease.

Immunix®

Sepsis ImmunoScore®

BioAegis Therapeutics Announces Collaboration with Prenosis to Advance AI-Driven Precision Medicine in Inflammatory Disease

Read More →

Resources

Blogs, articles, videos, and podcasts exploring how precision medicine and AI are changing the way clinicians detect and treat critical conditions.

Resource Library

Events

Treating the Patient, Not the Disease

Read More →

Newsroom

Read the latest Prenosis peer-reviewed articles and items from scholarly journals.

Newsroom

Sepsis ImmunoScore Outperforms Conventional Sepsis Tools

Read More →

About

As a biology-based technology company, we combine data science with AI to transform how critical conditions are diagnosed and treated.

Mission, Vision & Values

Careers

Leadership

Awards

LifeBridge Health deploys Prenosis’ FDA-authorized AI tool to speed sepsis detection

Read More →

Bobby Reddy, Jr., Ph.D.

Co-Founder / CEO / Board Member

Bobby has led the company from inception, driving company vision, building the team, securing clinical and strategic partnerships, and raising funds.

He has more than a decade of experience in the research and development of early screening technologies for debilitating diseases with a deep understanding of clinical issues. For several years, Bobby has worked intimately with a wide variety of clinical and administrative hospital personnel to comprehensively understand how technology can address the most critical issues they face. He received a Ph.D. in electrical engineering from the University of Illinois at Urbana-Champaign, an M.S. in electrical engineering from the University of California, Irvine, and B.S. degrees in computer engineering and electrical engineering from the University of California, Irvine.

Follow on LinkedIn

Bobby Reddy, Jr. in the News

Check out the latest thought leadership contributions on AI innovation and acute care from our co-founder, CEO and board member.

Treating the Patient, Not the Disease

Read More →

AI in Chicago: Breaking Through Healthcare’s Most Challenging Frontier

Read More →

Transforming Sepsis Care with AI: Prenosis Delivers Innovation

Read More →

Unite for Sepsis Symposium 2025: Highlights and Key Takeaways

Read More →

The Virtual Shift: Sepsis Awareness Month with Bobby Reddy, Jr., PhD

Read More →

Challenges Facing Developers of Diagnostic Tests for Sepsis: A Report From Sepsis Alliance and the Infection Management and Sepsis Collaborative Community

Read More →

Multivariate protein landscape of host response in hospitalised patients with suspected infection in the emergency department

Read More →

Bobby Reddy, Jr. Named to TIME’s 2025 TIME100 Health List

Read More →

Biomarker-based Clustering to Identify Distinct Host Response Signatures in Hospitalized Patients With Suspected Infection

Read More →

Prenosis CEO Bobby Reddy, Jr. Recognized Among Crain’s Chicago 40 Under 40

Read More →

Bobby Reddy, Jr. Discusses the Transformative Impact of AI on Sepsis Care–NewsNation Now

Read More →